Skip to main content
Stories
Careers
Contact
About Roche
About Roche
Business
Governance
Sustainability
Roche Global Citizenship
Strategy
Leadership
History
Solutions
Solutions
Focus areas
Pharma solutions
Diagnostic solutions
Product Development Pipeline
Innovation
Innovation
Partnering
Ethical standards
Team and structure
Innovation process
Clinical trials
Investors
Investors
Investor updates
Investor events
Reporting
Finance Information Tool
Share and Bond information
Download center
Frequently asked questions
Media
Media
Media releases
Media events
Media statements
Media library
About Roche
About Roche
Business
Business
Diagnostics
Pharma
Governance
Governance
Annual general meetings
Board of directors
Committees
Executive committee
Code of conduct
Sustainability
Sustainability
Approach
Goals and performance
ESG index
Safety health and wellbeing
Roche Global Citizenship
Roche Global Citizenship
Arts and culture
Community disaster relief
Humanitarian social development
React
Rebuiding communities
Science and education
Strategy
Leadership
History
Solutions
Solutions
Focus areas
Focus areas
Cardiometabolic
Haematology
Diabetes
Immunology
Infectious diseases
Inflammatory bowel diseases
Neurology
Oncology
Ophthalmology
Respiratory
Women's health
Pharma solutions
Pharma solutions
Safety reporting
Diagnostic solutions
Diagnostic solutions
Safety officers
Product Development Pipeline
Innovation
Innovation
Partnering
Partnering
Pharma
Diagnostics
Areas of interest
Ethical standards
Ethical standards
Advisory
Animal research
Genetics
Team and structure
Team and structure
R&D locations
Innovation process
Clinical trials
Investors
Investors
Investor updates
Investor events
Reporting
Finance Information Tool
Share and Bond information
Download center
Frequently asked questions
Media
Media
Media releases
Media events
Media statements
Media library
Stories
Careers
Contact
Worldwide
Neuromyelitis optica spectrum disorder
Explore more
Personalised Healthcare
Innovation
Data
Digital health